Kjell-Morten Myhr
Affiliations: | Department of Neurology | University of Bergen, Norway, Bergen, Hordaland, Norway |
Google:
"Kjell-Morten Myhr"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rød BE, Wergeland S, Bjørnevik K, et al. (2023) Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. Multiple Sclerosis and Related Disorders. 79: 105037 |
| Kapali A, Daltveit AK, Myhr KM, et al. (2023) Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. Journal of Neurology, Neurosurgery, and Psychiatry |
| Lie IA, Rød BE, Kvistad SS, et al. (2023) Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 70: 104530 |
| Hallin EI, Trætteberg Serkland T, Myhr KM, et al. (2022) Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry and Advances in the Clinical Lab. 25: 53-60 |
| Lie IA, Kaçar S, Wesnes K, et al. (2022) Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. Journal of Neurology, Neurosurgery, and Psychiatry |
| Nygaard GO, Torgauten H, Skattebøl L, et al. (2022) Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis. Multiple Sclerosis and Related Disorders. 62: 103812 |
| Grytten N, Myhr KM, Celius EG, et al. (2021) Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study. Multiple Sclerosis and Related Disorders. 55: 103209 |
| Norborg H, Riise T, Myhr KM, et al. (2021) Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 20552173211022027 |
| Wesnes K, Myhr KM, Riise T, et al. (2021) Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50: 102801 |
| Mosleth EF, Vedeler CA, Liland KH, et al. (2021) Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. Scientific Reports. 11: 4087 |